טוען...
Personalized medicine: applying ‘omics’ to lung fibrosis
Idiopathic pulmonary fibrosis (IPF), the most common fibrotic lung disease, is a chronic disease of unknown etiology with a very high mortality. Personalized medicine focuses on the use of the individual’s molecular and ‘omic’ (i.e., genomic, epigenomic and proteomic) information to direct more effi...
שמור ב:
| Main Authors: | , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2012
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3517740/ https://ncbi.nlm.nih.gov/pubmed/22917154 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/bmm.12.38 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|